Four New Projects Cross Multiple Therapeutic Areas, Including Oncology, Immunology, and Gastroenterology

MORRISVILLE, N.C. (Business Wire) April 27, 2010 — Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that the company has been awarded four projects across multiple therapeutic areas from four new clients. These projects range from managing smaller phase 1 trials to implementing a large global pivotal phase 3 trial.

Following industry trends crediting oncology products as one of the largest drivers of clinical development growth, Clinipace Worldwide has been granted two oncology-related trials, one Phase 2 and one Phase 3 trial. Other recently awarded projects include a Phase 1b rheumatoid arthritis study and Phase 3 gastroenterology trial.

“We are greatly energized by the way we started the year on such a positive note with these new client wins,” said Jeff Williams, CEO, Clinipace Worldwide. “As a dCRO – we build and use our technology to bring greater visibility to trial performance and service delivery, and our demonstrated ability to do so has really struck a chord with our clients.”

About Clinipace Worldwide

Clinipace Worldwide is a global digital clinical research organization (dCRO) specializing in fully-integrated clinical research services for biopharmaceutical and medical device firms. Optimized by TEMPO™, its proprietary eClinical platform, the Clinipace team of experts brings extensive knowledge and insight into site selection, patient recruitment, clinical operations, data management, medical monitoring, biostatistics, and regulatory affairs to ensure a successful clinical development program through proactive clinical trial management. With specific expertise in oncology, among other therapeutic areas, Clinipace Worldwide has managed over 90 contract research projects conducted at almost 3,000 sites with 100,000 patients. Clinipace Worldwide is headquartered in Research Triangle Park, NC with additional domestic operations in Overland Park, KS, and South American operations based in Brazil, Argentina, and Peru. For more information visit our website at